PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, University of Washington, Seattle, Washington, USA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.\', \'Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.\', \'University of Washington School of Pharmacy, Seattle, Washington, USA.\', \'University of Washington School of Medicine, Seattle, Washington, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/jmv.26674
?:doi
?:hasPublicationType
?:journal
  • Journal of medical virology
is ?:pmid of
?:pmid
?:pmid
  • 33200828
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33200828>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33200828>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all